Literature DB >> 11790818

Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats.

Ahmad I M Al-Shafei1, R G Wise, G A Gresham, G Bronns, T A Carpenter, L D Hall, Christopher L-H Huang.   

Abstract

A non-invasive cine magnetic resonance imaging (MRI) technique was developed to allow, for the first time, detection and characterization of chronic changes in myocardial tissue volume and the effects upon these of treatment by the angiotensin-converting enzyme (ACE) inhibitor captopril in streptozotocin (STZ)-diabetic male Wistar rats. Animals that had been made diabetic at the ages of 7, 10 and 13 weeks and a captopril-treated group of animals made diabetic at the age of 7 weeks were scanned. The findings were compared with the results from age-matched controls. All animal groups (n = 4 animals in each) were consistently scanned at 16 weeks. Left and right ventricular myocardial volumes were reconstructed from complete data sets of left and right ventricular transverse sections which covered systole and most of diastole using twelve equally incremented time points through the cardiac cycle. The calculated volumes remained consistent through all twelve time points of the cardiac cycle in all five experimental groups and agreed with the corresponding post-mortem determinations. These gave consistent myocardial densities whose values could additionally be corroborated by previous reports, confirming the validity of the quantitative MRI results and analysis. The myocardial volumes were conserved in animals whose diabetes was induced at 13 weeks but were significantly increased relative to body weight in animals made diabetic at 7 and 10 weeks. Captopril treatment, which was started immediately after induction of diabetes, prevented the development of this relative hypertrophy in both the left and right ventricles. We have thus introduced and validated quantitative MRI methods in a demonstration, for the first time, of chronic myocardial changes in both the right and left ventricles of STZ-diabetic rats and their prevention by the ACE inhibitor captopril.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790818      PMCID: PMC2290059          DOI: 10.1113/jphysiol.2001.012856

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  86 in total

Review 1.  Effects of angiotensin-converting enzyme inhibition on vascular remodeling of resistance vessels in hypertensive patients.

Authors:  M J Mulvany
Journal:  Metabolism       Date:  1998-12       Impact factor: 8.694

2.  Magnetic resonance imaging analysis of left ventricular function in normal and spontaneously hypertensive rats.

Authors:  R G Wise; C L Huang; G A Gresham; A I Al-Shafei; T A Carpenter; L D Hall
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

3.  Changes in diastolic function and collagen content in normotensive and hypertensive rats with long-term streptozotocin-induced diabetes.

Authors:  E Riva; G Andreoni; R Bianchi; R Latini; G Luvarà; G Jeremic; C Traquandi; L Tuccinardi
Journal:  Pharmacol Res       Date:  1998-03       Impact factor: 7.658

4.  Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy.

Authors:  B Rodrigues; M C Cam; J Kong; R K Goyal; J H McNeill
Journal:  Cardiovasc Res       Date:  1997-04       Impact factor: 10.787

5.  Wall stress-induced arrhythmias in the working rat heart as left ventricular hypertrophy regresses during captopril treatment.

Authors:  G R Dalton; J V Jones; S J Evans; A J Levi
Journal:  Cardiovasc Res       Date:  1997-03       Impact factor: 10.787

Review 6.  Effects of angiotensin converting enzyme inhibition on vascular remodelling of resistance vessels in hypertensive patients.

Authors:  M J Mulvany
Journal:  J Hypertens Suppl       Date:  1996-12

7.  A quantitative description of dynamic left ventricular geometry in anaesthetized rats using magnetic resonance imaging.

Authors:  J J Crowley; C L Huang; A R Gates; A Basu; L M Shapiro; T A Carpenter; L D Hall
Journal:  Exp Physiol       Date:  1997-09       Impact factor: 2.969

8.  Effect of long-term treatment with enalapril in streptozotocin diabetic and DOCA hypertensive rats.

Authors:  R K Goyal; M C Satia; R A Bangaru; T P Gandhi
Journal:  J Cardiovasc Pharmacol       Date:  1998-08       Impact factor: 3.105

9.  Effects of streptozotocin-induced diabetes on heart rate, blood pressure and cardiac autonomic nervous control.

Authors:  K K Hicks; E Seifen; J R Stimers; R H Kennedy
Journal:  J Auton Nerv Syst       Date:  1998-03-03

10.  The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats.

Authors:  R Rösen; A F Rump; P Rösen
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

View more
  12 in total

Review 1.  Current status of cardiac MRI in small animals.

Authors:  J-P Vallée; M K Ivancevic; D Nguyen; D R Morel; M Jaconi
Journal:  MAGMA       Date:  2004-12-16       Impact factor: 2.310

2.  Characterization of alterations in diabetic myocardial tissue using high resolution MRI.

Authors:  Rajaprasad Loganathan; Mehmet Bilgen; Baraa Al-Hafez; Irina V Smirnova
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-13       Impact factor: 2.357

3.  Evaluation of a multi-pinhole collimator for imaging small animals with different sizes.

Authors:  Greta S P Mok; Jianhua Yu; Yong Du; Yuchuan Wang; Benjamin M W Tsui
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

Review 4.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 5.  A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy.

Authors:  Xinli Zhang; Chen Chen
Journal:  Endocrine       Date:  2012-02-10       Impact factor: 3.633

Review 6.  Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review.

Authors:  Ernest Adeghate
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

7.  Guan Xin Dan Shen formulation protects db/db mice against diabetic cardiomyopathy via activation of Nrf2 signaling.

Authors:  Bin Zhang; Chen-Yang Zhang; Xue-Lian Zhang; Gui-Bo Sun; Xiao-Bo Sun
Journal:  Mol Med Rep       Date:  2021-05-26       Impact factor: 2.952

8.  Pulmonary arterial dysfunction in insulin resistant obese Zucker rats.

Authors:  Javier Moral-Sanz; Carmen Menendez; Laura Moreno; Enrique Moreno; Angel Cogolludo; Francisco Perez-Vizcaino
Journal:  Respir Res       Date:  2011-04-22

9.  Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging.

Authors:  Rajprasad Loganathan; Mehmet Bilgen; Baraa Al-Hafez; Mohammed D Alenezy; Irina V Smirnova
Journal:  Cardiovasc Diabetol       Date:  2006-04-04       Impact factor: 9.951

10.  Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment.

Authors:  Jun Lu; Beau Pontré; Stephen Pickup; Soon Y Choong; Mingming Li; Hong Xu; Gregory D Gamble; Anthony R J Phillips; Brett R Cowan; Alistair A Young; Garth J S Cooper
Journal:  Cardiovasc Diabetol       Date:  2013-01-31       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.